CLIA Sceeen In-Viro™
6 Panel CSI Cup, CLIA Screen In-Vitro™ Rapid Drug Test Cup, CSI-CUP-264, 25/Box
- SKU:
- CSI-CUP-264
- MPN:
- CSI-CUP-264
Description
6 Panel CSI Cup - CLIA Screen In-Vitro™ Drug Test, 25/Case
The best selling CSI Cup (CLIA Screen In-Vitro™) Multi-Panel Drug Test Cup is a No Step, fully integrated self contained multi-drug screening cup. No tipping or turning required. Read results in 5 minutes. The cup is FDA Cleared and CLIA Waived. This cup is a fast visual, competitive panel immunoassay that can be used for the simultaneous, qualitative detection of multiple drug metabolites at specific cutoff levels in human urine.
Features & Benefits
- CLIA Waived
- FDA 510(K) Approved
- Health Canada Approved
- Sold by the Case of 25 tests
- New "Click Seal" cap is securely sealed with the “CLICK”
- No step cup
- Up to 99% Accurate
- Dual scale Temperature Strip verifies if urine is "fresh" and not diluted
- Adheres to the SAMHSA Cutoff Levels
- Immediate Results
- Shelf-life up to 24 months
- New easy to open top for the confirmation lab
Download & Print Reference Materials
CLIA Screen In Vitro Cup (CLIA Waived) Drug Test Package Insert
CLIA Screen In Vitro Cup (CLIA Waived) Drug Test Instruction Sheet
6 Panel Configuration (Choose Above) | ||
Item Number | Drugs Tested | Approvals |
CSI-CUP-264 | AMP, BZO, COC, MET, OPI, THC | FDA 510(k) Cleared CLIA Waived OTC - Over the Counter Health Canada Approved |
Drug Detection Times in Urine | ||||
Drug Name | Abbreviation | Cutoff | Detection Times* | Certifications/Clearances |
Amphetamine | AMP | 500 or 1000 ng/mL | 2 hours to 4 days | FDA / CLIA-Waived |
Barbiturates | BAR | 300 ng/ml | 2 hours to 3 days | FDA / CLIA-Waived |
Benzodiazepines | BZO | 300 ng/ml | 2 hours to 4 days | FDA / CLIA-Waived |
Buprenorphine / Suboxone | BUP | 10 ng/ml | 2 hours to 3 days | FDA / CLIA-Waived |
Cocaine | COC | 150 or 300 ng/ml | 1 hour to 4 days | FDA / CLIA-Waived |
Ecstasy | MDMA | 500 ng/ml | 2 hours to 4 days | FDA / CLIA-Waived |
Cannabinoids / Marijuana | THC | 50 ng/ml | 2 hours to 4 days | FDA / CLIA-Waived |
Methadone | MTD | 300 ng/ml | 3 hours to 3 days | FDA / CLIA-Waived |
Methadone Metabolite | EDDP | 300 ng/ml | 1 hour to 3 days | FDA / CLIA-Waived |
Methamphetamine | mAMP | 500 or 1000 ng/ml | 2 hours to 4 days | FDA / CLIA-Waived |
Morphine / Opiates | MOP / OPI | 300 or 2000 ng/mL | 2 hours to 3 days | FDA / CLIA-Waived |
Oxycodone | OXY | 100 ng/ml | 1 hour to 2 days | FDA / CLIA-Waived |
Phencyclidine | PCP | 25 ng/ml | 4 hours to 14 days | FDA / CLIA-Waived |
Propoxyphene | PPX | 300 ng/ml | 1 hour to 3 days | FDA / CLIA-Waived |
Tricyclic Antidepressants / Nortriptyline | TCA | 1000 ng/ml | 8 hours to 7 days | FDA / CLIA-Waived |
* Detection times are not guaranteed. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatogrphy/Mass Spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated. |